Kyverna Therapeutics, Inc. Share Price
NASDAQ: KYTX | Small CapKyverna Therapeutics, Inc. Stock Performance
Open $8.09 | Prev. Close $7.72 | Circuit Range N/A |
Day Range $7.78 - $8.09 | Year Range $2.81 - $13.60 | Volume 23,986 |
Average Traded $7.91 |
Kyverna Therapeutics, Inc. Share Price Today
As of 10 August 2026, Kyverna Therapeutics, Inc.'s share price is $7.96. The stock opened at $8.09, compared to its previous close of $7.72. During today's trading session, Kyverna Therapeutics, Inc.'s share price traded between $7.78 and $8.09, with an average price of $7.94. Over the past 52 weeks, the stock has recorded a high of $13.60 and a low of $2.81. In terms of performance, Kyverna Therapeutics, Inc.'s share price has declined by 3.16% over the last six months and is up 114.27% on a year-on-year basis.
Kyverna Therapeutics, Inc. Share Price Chart
Kyverna Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $352.31M | PE Ratio (TTM) -2.19 | Dividend Yield N/A |
EPS (TTM) $-3.64 | Revenue (TTM) N/A | Return On Equity (TTM) -69.45% |
Profit Margin N/A | Debt to Equity 0.16 | Quarterly Earnings Growth YoY -6.65% |
Kyverna Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
About Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc., clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. The company's lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome and myasthenia gravis that is in phase 2 clinical trial; and for lupus nephritis. It is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing, as well as KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Kyverna Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $7.30 | $7.96 | +9.04% |
Jul 2026 | $8.91 | $7.30 | -17.98% |
Jun 2026 | $8.46 | $8.90 | +4.64% |
May 2026 | $8.77 | $8.51 | -3.68% |
Apr 2026 | $8.66 | $8.83 | +2.08% |
Mar 2026 | $7.88 | $8.65 | +5.23% |
Feb 2026 | $7.91 | $8.22 | +2.62% |
Jan 2026 | $9.46 | $8.01 | -14.61% |
Dec 2025 | $7.38 | $9.38 | +21.82% |
Nov 2025 | $6.98 | $7.70 | +10.63% |
Oct 2025 | $6.07 | $6.96 | +16.19% |
Sep 2025 | $3.60 | $5.99 | +61.24% |
KYTX Share Price FAQs
What is Kyverna Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Kyverna Therapeutics, Inc. stock?
What is KYTX's market capitalisation today?
What is KYTX's net income for the last quarter?
What is the 5 year returns of KYTX?
What is the high & low stock price of KYTX today?
Can I buy KYTX shares in India?